Turning Point’s Therapeutics’ Vivian Nguyen works in the company’s La Jolla lab. Photo courtesy of Jamie Scott Lytle.

Turning Point’s Therapeutics’ Vivian Nguyen works in the company’s La Jolla lab. Photo courtesy of Jamie Scott Lytle.

A class of drugs called tyrosine kinase inhibitors proved to be a breakthrough in cancer...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129